# HFNC Treatment in COVID-19 Pneumonia

> **NCT04424836** · — · COMPLETED · sponsor: **Sisli Hamidiye Etfal Training and Research Hospital** · enrollment: 43 (actual)

## Conditions studied

- Coronavirus Infection
- Pneumonia, Viral
- Acute Respiratory Failure

## Interventions

- **DEVICE:** high flow nasal cannula device

## Key facts

- **NCT ID:** NCT04424836
- **Lead sponsor:** Sisli Hamidiye Etfal Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-15
- **Primary completion:** 2020-06-04
- **Final completion:** 2020-06-05
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2020-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04424836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04424836, "HFNC Treatment in COVID-19 Pneumonia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04424836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*